Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting
-
Mawson Receives Final Order for Arrangement with First Nordic Metals
-
IREN Closes $2.3 Billion Convertible Notes Offering and the Repurchase of Existing Convertible Notes
-
Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries
-
SKG Unveils Top Tech Wellness Gifts for Christmas 2025 – Revolutionary Neck & Foot Massagers for Instant Pain Relief
-
TEN Ltd. Receives Best Deal of the Year Award at the 2025 Lloyds List Greek Shipping Awards
-
Interfor Announces Appointment of Chief Financial Officer; Chief Operating Officer
-
Netcapital Inc. Announces Appointment of Rich Wheeless as CEO
-
SKG Unveils Top Tech Wellness Gifts for Christmas 2025 – Revolutionary Neck & Foot Massagers for Instant Pain Relief
-
Nayax Announces Preliminary Results of Notes and Warrants Offering in Israel to Qualified Investors
-
Capstone Infrastructure Corporation and Wei Wai Kum First Nation Announce Renaming and New Artwork for Yəyus Energy
-
Aeroméxico November 2025 Traffic Results
-
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
-
United Community Banks, Inc. Announces Extension of Share Repurchase Program
-
Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch
-
FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director
-
Toll Brothers Reports FY 2025 Fourth Quarter Results
-
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
-
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
-
Vornado Declares Common Dividend of $.74 Per Share
-
Arizona State Card Show Will Have $50 Million Worth of Sports and Pokemon Cards On Display
-
Microchip Technology to Present at the Barclays 23rd Annual Global Technology Conference
-
Latham Group Appoints Sean Gadd as Chief Executive Officer
-
Global Ship Lease Declares Quarterly Dividend on its 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares
-
ONEOK to Participate in Investor Conference
-
Broadway Star Morgan Dudley Joins Stargaze as Creative Advisor
-
Oportun to Present at Sidoti December Virtual Investor Conference
-
S.T. Dupont - Information Financière 30 septembre 2025
-
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
-
Orion Group Holdings to Participate in the Roth Capital Partners 14th Annual Deer Valley Event
-
Comscore Releases 2025 AI Intelligence Report: Establishing New Benchmarks for Generative AI Adoption and Influence
-
Paramount Gold Nevada Receives Draft Consolidated Permit Package From the State of Oregon for the Grassy Mountain Gold Project
-
S.T. Dupont - Mise à disposition du Rapport Financier Semestriel 30 septembre 2025
-
Oil-Dri Announces Second Highest Quarterly Earnings in History
-
Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025
-
Reed’s, Inc. Announces Closing of $10 Million Public Offering and Uplisting to NYSE American Stock Exchange
-
Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2
-
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rat
-
Mama’s Creations Reports Third Quarter Fiscal 2026 Financial Results
-
Protara Announces Closing of $75 Million Public Offering
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
-
Kymera Therapeutics Announces Proposed Public Offering
-
Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants
-
Kite Realty Group Completes $474 Million in Dispositions and $86.1 Million of Additional Share Repurchases
-
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
-
Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock
-
Ascent Solar Technologies Announces Closing of Up to $5.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri
-
Camposol S.A. Commences Tender Offer for Any and All of Its 6.000% Notes Due 2027
